|
Home : Medical Devices : Gadolinium & Nephrogenic Systemic Fibrosis (NSF) : Newsfeeds : AAN: Skin Patch Induces MS Immune Tolerance AAN: Skin Patch Induces MS Immune Tolerance
Patients had to have had at least one relapse during the previous year. The trial's primary endpoint was the cumulative number of gadolinium-enhancing MRI lesions per patient. After one year, the results in this measure were 0.0255 in the placebo group ...
Find a Gadolinium & Nephrogenic System Fibrosis (NSF) Lawyer Now
This form is secure and encrypted. More information about secure forms and your privacy here.
|




